The Treatment of Cardiovascular Disease with
... can be used to screen diseases, such as cardiovascular disease (Donald, & Clayton eds. 2001). The heart-health biomarkers commonly viewed in assessing the health of the heart are: blood pressure (BP), heart rate, cholesterol levels (the high-density and the low-density lipids [HDL/LDL]), C- reactive ...
... can be used to screen diseases, such as cardiovascular disease (Donald, & Clayton eds. 2001). The heart-health biomarkers commonly viewed in assessing the health of the heart are: blood pressure (BP), heart rate, cholesterol levels (the high-density and the low-density lipids [HDL/LDL]), C- reactive ...
Case Scenarios - Ohio-ACC
... normal limits, with BNP of 12,279. His white count is 8.1 with Hgb of 13.6 and Hct of 43.7 and platelet count of 2120,000; BUN of 18 and Creatinine of 1.5. Unfortunately, however, patient is started on continuous veno-venous hemofiltration ( CVVHD) for the CHF. Past Medical History-Significant for a ...
... normal limits, with BNP of 12,279. His white count is 8.1 with Hgb of 13.6 and Hct of 43.7 and platelet count of 2120,000; BUN of 18 and Creatinine of 1.5. Unfortunately, however, patient is started on continuous veno-venous hemofiltration ( CVVHD) for the CHF. Past Medical History-Significant for a ...
Assessment of cardiovascular risk by use of multiple-risk
... modification of its causes. The most dramatic advance has been the demonstration that aggressive medical therapy will substantially reduce the likelihood of recurrent major coronary syndromes in patients with established CHD (secondary prevention). The American Heart Association (AHA) and the Americ ...
... modification of its causes. The most dramatic advance has been the demonstration that aggressive medical therapy will substantially reduce the likelihood of recurrent major coronary syndromes in patients with established CHD (secondary prevention). The American Heart Association (AHA) and the Americ ...
Acute Rheumatic Fever and Rheumatic Heart Disease
... Can acute rheumatic fever and rheumatic heart disease be prevented? Yes, following an attack of acute rheumatic fever preventive treatment for group A Streptococcus infection is needed to stop further attacks of acute rheumatic fever and prevent further heart damage. Preventive treatment for group A ...
... Can acute rheumatic fever and rheumatic heart disease be prevented? Yes, following an attack of acute rheumatic fever preventive treatment for group A Streptococcus infection is needed to stop further attacks of acute rheumatic fever and prevent further heart damage. Preventive treatment for group A ...
Search for: 10 or 12
... devastating. There have not been any reports to date describing the frequency and causes of sudden death in sport in the Republic of Ireland. AIM: To describe the incidence, possible causes, associated factors, and pathological findings in people who died while exercising in the Republic of Ireland ...
... devastating. There have not been any reports to date describing the frequency and causes of sudden death in sport in the Republic of Ireland. AIM: To describe the incidence, possible causes, associated factors, and pathological findings in people who died while exercising in the Republic of Ireland ...
Chapter 1 - Mains Associates
... circulation. It is this pressure that, compared to MAP, represents the pressure differential across which blood flows. It also represents the blood “available” to be picked up by the right atrium before each contraction cycle. If the heart is weak and can’t move blood along quickly enough, blood “ba ...
... circulation. It is this pressure that, compared to MAP, represents the pressure differential across which blood flows. It also represents the blood “available” to be picked up by the right atrium before each contraction cycle. If the heart is weak and can’t move blood along quickly enough, blood “ba ...
Clinical Determinants of Left Ventricular Ejection Fraction
... also increase in afterload that produce a large decrease in stroke volume (23). Also, elevated blood pressure can increase cardiac workload, which leads to the development of left ventricular hypertrophy, LV mass, as well as relatively increased wall thickness. These abnormalities cause reduced LVEF ...
... also increase in afterload that produce a large decrease in stroke volume (23). Also, elevated blood pressure can increase cardiac workload, which leads to the development of left ventricular hypertrophy, LV mass, as well as relatively increased wall thickness. These abnormalities cause reduced LVEF ...
Circulating levels of persistent organic pollutants (POPs) are associated with left
... reported stroke, 3.8% congestive heart failure, and 9% diabetes mellitus. Almost half the cohort reported any cardiovascular medication (45%), with antihypertensive medication being the most prevalent (32%). Fifteen percent reported use of statins, while insulin and oral antiglycemic drugs were repo ...
... reported stroke, 3.8% congestive heart failure, and 9% diabetes mellitus. Almost half the cohort reported any cardiovascular medication (45%), with antihypertensive medication being the most prevalent (32%). Fifteen percent reported use of statins, while insulin and oral antiglycemic drugs were repo ...
Pulmonary Heart Disease
... Each of the patients selected was suffering from some form of chronic pulmonary disease complicated by the co-existence of heart disease with right ventricular involvement. The latter was indicated by clinical findings such as signs of right-sided heart failure, or by radiologic or electrocardiograp ...
... Each of the patients selected was suffering from some form of chronic pulmonary disease complicated by the co-existence of heart disease with right ventricular involvement. The latter was indicated by clinical findings such as signs of right-sided heart failure, or by radiologic or electrocardiograp ...
DIAbETIC CArDIoMyoPATHy - The Association of Physicians of India
... Treatment of overt congestive heart failure is more or less similar to treatment of congestive heart failure due to any other cause. Novel therapy for treatment of diabetic cardiomyopathy is need of the hour. ...
... Treatment of overt congestive heart failure is more or less similar to treatment of congestive heart failure due to any other cause. Novel therapy for treatment of diabetic cardiomyopathy is need of the hour. ...
Ask Doctor Clarke
... • Collapsing pulses: the shunting leads to extra blood flow through the lungs and hence extra blood returning to the left of the heart (volume overload) • Extra blood ejected from LV causes high systolic pulse pressure • Rapid “run-off” through the ductus leads to low diastolic pressure ...
... • Collapsing pulses: the shunting leads to extra blood flow through the lungs and hence extra blood returning to the left of the heart (volume overload) • Extra blood ejected from LV causes high systolic pulse pressure • Rapid “run-off” through the ductus leads to low diastolic pressure ...
Chapter 14
... • Myocardial infarction: lack of blood flow to the heart muscle with resulting death of heart tissue, often called a heart attack • Coronary thrombosis: blockage of a coronary artery by a blood clot that may cause sudden death • Angina: pain, pressure, heaviness, or tightness in the center of the ch ...
... • Myocardial infarction: lack of blood flow to the heart muscle with resulting death of heart tissue, often called a heart attack • Coronary thrombosis: blockage of a coronary artery by a blood clot that may cause sudden death • Angina: pain, pressure, heaviness, or tightness in the center of the ch ...
Circadian Variation of Paroxysmal Supraventricular Tachycardia*
... Previous studies have shown that the onset of PSVT increased during the daytime and decreased at night.14,16 However, Kupari et al15 showed no morning peak in the onset of PSVT. In these studies, researchers investigated the distribution of the onset of symptomatic PSVT episodes causing admission to ...
... Previous studies have shown that the onset of PSVT increased during the daytime and decreased at night.14,16 However, Kupari et al15 showed no morning peak in the onset of PSVT. In these studies, researchers investigated the distribution of the onset of symptomatic PSVT episodes causing admission to ...
Publication - American Heart Association
... light intensity. Corlanor can cause phosphenes, thought to be mediated through Corlanor’s effects on retinal photoreceptors [see Clinical Pharmacology (12.1)]. Onset is generally within the first 2 months of treatment, after which they may occur repeatedly. Phosphenes were generally reported to be o ...
... light intensity. Corlanor can cause phosphenes, thought to be mediated through Corlanor’s effects on retinal photoreceptors [see Clinical Pharmacology (12.1)]. Onset is generally within the first 2 months of treatment, after which they may occur repeatedly. Phosphenes were generally reported to be o ...
Circadian Variation of Paroxysmal Supraventricular Tachycardia*
... Previous studies have shown that the onset of PSVT increased during the daytime and decreased at night.14,16 However, Kupari et al15 showed no morning peak in the onset of PSVT. In these studies, researchers investigated the distribution of the onset of symptomatic PSVT episodes causing admission to ...
... Previous studies have shown that the onset of PSVT increased during the daytime and decreased at night.14,16 However, Kupari et al15 showed no morning peak in the onset of PSVT. In these studies, researchers investigated the distribution of the onset of symptomatic PSVT episodes causing admission to ...
AF and Venous Thromboembolism – Pathophysiology, Risk
... may cause direct injury to the vessels resulting in exposure of the subendothelial tissue factor (TF). This however, is not common in non-surgical patients with VTE. Venous stasis promotes thrombus formation by not flushing out the activated coagulation factors from endothelial dysfunction. Circulat ...
... may cause direct injury to the vessels resulting in exposure of the subendothelial tissue factor (TF). This however, is not common in non-surgical patients with VTE. Venous stasis promotes thrombus formation by not flushing out the activated coagulation factors from endothelial dysfunction. Circulat ...
Chronic Stable Angina - Hellenic Journal of Cardiology
... of life in the group who underwent PCI. Over a fouryear follow up there was no difference in mortality between the two groups. Therefore, invasive treatment could be used in elderly patients with refractory angina in order to relieve their symptoms, without promising any prolongation of life. Hambre ...
... of life in the group who underwent PCI. Over a fouryear follow up there was no difference in mortality between the two groups. Therefore, invasive treatment could be used in elderly patients with refractory angina in order to relieve their symptoms, without promising any prolongation of life. Hambre ...
Management of Chronic Heart Failure in General
... • 5% of all medical admissions • £716M per annum • 1.8% of total NHS budget • 70% due to hospitalisations • Heart failure “the growing epidemic” • Admissions predicted to rise by 50% over the next 25 years British Heart Foundation, 2002 ...
... • 5% of all medical admissions • £716M per annum • 1.8% of total NHS budget • 70% due to hospitalisations • Heart failure “the growing epidemic” • Admissions predicted to rise by 50% over the next 25 years British Heart Foundation, 2002 ...
Potential role of nutritional factors
... results are significant since platelet activation plays a significant role in atherosclerosis and CAD and platelets have a role in inflammation (38). Thus, PUFAs (especially n-3 series and in particular, EPA and DHA) are beneficial in the prevention of atherosclerosis, CAD, HF and its associated com ...
... results are significant since platelet activation plays a significant role in atherosclerosis and CAD and platelets have a role in inflammation (38). Thus, PUFAs (especially n-3 series and in particular, EPA and DHA) are beneficial in the prevention of atherosclerosis, CAD, HF and its associated com ...
Carotid Artery Disease
... Strokes result either from obstruction of blood flow to the brain by the plaque or when bits of plaque and clots break off from the plaque and flow to the brain. If left untreated, carotid artery disease may lead to stroke. Depending on its severity, a stroke can be fatal. In fact, strokes are the t ...
... Strokes result either from obstruction of blood flow to the brain by the plaque or when bits of plaque and clots break off from the plaque and flow to the brain. If left untreated, carotid artery disease may lead to stroke. Depending on its severity, a stroke can be fatal. In fact, strokes are the t ...
Atrial Fibrillation
... January CT, Wann LS, Alpert JS et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014; 64: e1-76. ...
... January CT, Wann LS, Alpert JS et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014; 64: e1-76. ...
Coronary Artery Sequel of Kawasaki Disease in Adulthood, a
... tidak mempunyai faktor risiko yang bermakna. Vaskulitis koroner akibat penyakit Kawasaki turut berperan sebagai faktor risiko pada populasi dewasa muda dan menimbulkan kejadian koroner akut. Penyakit Kawasaki terutama menyerang di masa kanak-kanak, menyebabkan vaskulitis arteri koroner dan hal ini m ...
... tidak mempunyai faktor risiko yang bermakna. Vaskulitis koroner akibat penyakit Kawasaki turut berperan sebagai faktor risiko pada populasi dewasa muda dan menimbulkan kejadian koroner akut. Penyakit Kawasaki terutama menyerang di masa kanak-kanak, menyebabkan vaskulitis arteri koroner dan hal ini m ...
Cardiovascular System
... b. Bicuspid/mitral valve – between the left atrium and the left ventricle 4. Semilunar Valves – three half-moon pockets that catch blood and balloon out to close the opening a. Pulmonary semilunar valve – between the right ventricle and the pulmonary arteries b. Aortic semilunar valve – between the ...
... b. Bicuspid/mitral valve – between the left atrium and the left ventricle 4. Semilunar Valves – three half-moon pockets that catch blood and balloon out to close the opening a. Pulmonary semilunar valve – between the right ventricle and the pulmonary arteries b. Aortic semilunar valve – between the ...
Cardiovascular disease
Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. Cardiovascular disease includes coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack). Other CVDs are stroke, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, atrial fibrillation, congenital heart disease, endocarditis, aortic aneurysms, peripheral artery disease and venous thrombosis.The underlying mechanisms vary depending on the disease in question. Coronary artery disease, stroke, and peripheral artery disease involve atherosclerosis. This may be caused by high blood pressure, smoking, diabetes, lack of exercise, obesity, high blood cholesterol, poor diet, and excessive alcohol consumption, among others. High blood pressure results in 13% of CVD deaths, while tobacco results in 9%, diabetes 6%, lack of exercise 6% and obesity 5%. Rheumatic heart disease may follow untreated strep throat.It is estimated that 90% of CVD is preventable. Prevention of atherosclerosis is by decreasing risk factors through: healthy eating, exercise, avoidance of tobacco smoke and limiting alcohol intake. Treating high blood pressure and diabetes is also beneficial. Treating people who have strep throat with antibiotics can decrease the risk of rheumatic heart disease. The effect of the use of aspirin in people who are otherwise healthy is of unclear benefit. The United States Preventive Services Task Force recommends against its use for prevention in women less than 55 and men less than 45 years old; however, in those who are older it is recommends in some individuals. Treatment of those who have CVD improves outcomes.Cardiovascular diseases are the leading cause of death globally. This is true in all areas of the world except Africa. Together they resulted in 17.3 million deaths (31.5%) in 2013 up from 12.3 million (25.8%) in 1990. Deaths, at a given age, from CVD are more common and have been increasing in much of the developing world, while rates have declined in most of the developed world since the 1970s. Coronary artery disease and stroke account for 80% of CVD deaths in males and 75% of CVD deaths in females. Most cardiovascular disease affects older adults. In the United States 11% of people between 20 and 40 have CVD, while 37% between 40 and 60, 71% of people between 60 and 80, and 85% of people over 80 have CVD. The average age of death from coronary artery disease in the developed world is around 80 while it is around 68 in the developing world. Disease onset is typically seven to ten years earlier in men as compared to women.